PRO32 DE NOVO ECONOMIC MODEL TO ASSESS THE IMPACT OF SIZE AND DURABILITY OF EFFECT OF CURATIVE CELL AND GENE THERAPIES IN TREATMENT OF PATIENTS WITH CONGENITAL DYSERYTHROPOIETIC ANEMIA (CDA)
Abstract
Authors
E. Priedane R. Gomes-Faria